D09535 | |
D number | D09535 |
Classification | Drug |
Name | Mirabegron (USAN/JAN); Myrbetriq (TN) |
Component | - |
Formula | C21H24N4O2S |
Exact mass | 396.162 |
Mol weight | 396.5059 |
Structural formula | ![]() |
Sequence | - |
Sequence type | - |
Source | - |
Upper DGroup | Cardiovascular agent DG01456 Adrenergic receptor agonist DG01455 beta-Adrenergic receptor agonist DG01453 beta3-Adrenergic receptor agonist Cyp inhibitor DG01645 CYP2D6 inhibitor |
Remark | Therapeutic category: 2590 ATC code: G04BD12 Chemical group: DG02555 |
Activity | - |
Disease | - |
Comment | - |
Target | ADRB3 [HSA:155] [KO:K04143] |
Metabolism | Enzyme: CYP3A4 [HSA:1576] |
Interaction | CYP inhibition: CYP2D6 [HSA:1565] |
Other DBs | CAS: 223673-61-8 PubChem: 96026215 ChEBI: 65349 ChEMBL: CHEMBL2095212 LigandBox: D09535 |
KCF data | - |